🧠As we reach the last day of Alzheimer’s Month, Pharmidex reaffirms our commitment to supporting the fight against this devastating disease. 💜
September 30, 2024
Alzheimer’s not only impacts those diagnosed, but also their families, caregivers, and communities. At
Pharmidex, we stand with them, dedicated to offering our expertise in preclinical research to advance innovative treatments and therapies.
Our goal is to bring hope and progress to those facing the challenges of Alzheimer’s, working toward a future where the disease no longer robs us of our loved ones.
To the patients and families navigating this difficult journey, we are here to help, with science, compassion, and unwavering determination.

Together, we can drive change and find better solutions.
#AlzheimersMonth #FightAlzheimers #PharmidexResearch #HealthcareInnovation #DrugDiscovery #SupportingFamilies
We’re pleased to share that Janette Dalay Robertson , Business Development Manager at Pharmidex , will attend the DDW Turning Science into Business Symposium 2025 on Tuesday, 4th November, at the The Francis Crick Institute , London. Janette looks forward to connecting with industry leaders and exploring new collaboration opportunities.
We’re delighted to announce that Pharmidex will present our poster "Driving breakthroughs in Parkinson’s & neurodegeneration research” at the upcoming RSC BMCS meeting. With over 23 years of CNS expertise, we support biopharma partners in developing new therapies for Parkinson’s disease and tauopathies, through: 🔹 Parkinson’s & neurodegeneration models 🔹 Transgenic CNS lines (incl. 5xFAD) 🔹 Biomarker & BBB penetration studies Join us in Cambridge to explore how our GLP-accredited CNS platforms accelerate discovery and development.
Pharmidex is pleased to share that Ash Alavijeh , our Head of Operations, will be attending the Life Sciences Wallonia Business Forum this evening at the Residence of the Belgian Ambassador. Hosted by the Economic Counsellor of Belgium-Wallonia Investment & Trade, the event brings together leading organisations across the European life sciences sector to explore how Wallonia supports international growth both financially and strategically. We look forward to connecting with international partners and exploring opportunities for collaboration and innovation in the European life sciences ecosystem.
